Christina Emery
About Christina Emery
Christina Emery (51) serves as President of Barings Corporate Investors (MCI) and has held this role since 2020; she previously served as Vice President (2018–2020). Emery is a long-tenured Barings executive—Managing Director since 2011 and Director from 2005–2011—and is also Trustee and President of CI Subsidiary Trust and PI Subsidiary Trust . Her active officer status is evidenced by signing the 2025 Form N‑PX as President on August 28, 2025 . The proxy does not disclose individual performance metrics (e.g., TSR, revenue or EBITDA growth) tied to her compensation at the Trust level .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Barings Corporate Investors (MCI) | President | Since 2020 | Senior leadership of the Trusts; officer role disclosed (no performance or compensation specifics in proxy) |
| Barings Corporate Investors (MCI) | Vice President | 2018–2020 | Officer role prior to presidency |
| Barings LLC | Managing Director | Since 2011 | Senior investment-management leadership at the adviser to the Trusts |
| Barings LLC | Director | 2005–2011 | Investment management leadership prior to MD |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| CI Subsidiary Trust | Trustee and President | Since 2020 | Sister trust roles |
| PI Subsidiary Trust | Trustee and President | Since 2020 | Sister trust roles |
Fixed Compensation
- Officers’ compensation and expenses (including the President) are paid by Barings under the Investment Services Contract; MCI does not pay compensation to “interested” Trustees or Barings/MassMutual employees serving as officers .
- The proxy does not disclose Christina Emery’s base salary, target bonus, or actual bonus; these are determined and paid by Barings and are not reported by MCI .
Performance Compensation
- No RSUs/PSUs/options or performance metrics tied to officer compensation are disclosed at the Trust level for Christina Emery (compensation is paid by Barings, not MCI) .
Equity Ownership & Alignment
- Individual officer share ownership for Christina Emery is not disclosed; the proxy provides only group-level data and individual Trustee ranges .
- Independent Trustee ownership requirement: each Independent Trustee must invest one year’s worth of fees (excluding committee fees) in MCI/MPV shares; a three‑year phase‑in applies for new Trustees .
Ownership Context
| Metric | 2023 | 2025 |
|---|---|---|
| Trustees & Officers as a group – % of MCI shares | 2.17% | 1.95% |
| Barings (investment adviser) – % of MCI shares | 1.08% | 1.07% |
- Multiple officer Form 3 filings for other MCI officers (e.g., compliance/legal) report “No securities are beneficially owned,” indicating limited direct insider ownership at the officer level; no Form 3 for Christina Emery was identified in the Trust’s filings .
Employment Terms
- Officers hold their positions until a successor is duly elected and qualified; no fixed term, severance, or change‑of‑control terms are disclosed for officers at the Trust level .
- Christina Emery is documented as President in officer rosters and via the 2025 N‑PX signature block (President), confirming active tenure and authority for SEC reporting .
Investment Implications
- Pay-for-performance analysis at the Trust level is not possible for Christina Emery given compensation is paid by Barings and not disclosed in MCI proxies; alignment is primarily through Barings’ employment and incentive structures rather than explicit MCI TSR/revenue/EBITDA targets .
- Limited disclosed insider ownership at the officer level (with group ownership 1.95% in 2025) suggests low direct selling pressure from officers; any insider trading signals for MCI are likely muted relative to operating companies with executive equity programs .
- Retention risk appears moderate: long tenure at Barings (MD since 2011) and continuous service at MCI (VP then President since 2018/2020), with officer positions continuing until successors are appointed; however, no employment contract, severance, or change‑of‑control economics are disclosed at the Trust level .
- Governance and oversight are robust at the Board/Trust level (Audit Committee and Independent Trustees), but compensation levers for the President are outside the Trust and reside with Barings, making shareholder evaluation of officer incentive alignment reliant on adviser‑level disclosures rather than MCI filings .